Table 1 Clinical characteristics of the patients at diagnosis
From: Predictors of outcome in idiopathic rapidly progressive glomerulonephritis (IRPGN)
n | 34 |
Gender (M:F) | 17:17 (ratio 1:1) |
Age (years) | 55.7 ± 17 (range 25–80 years) |
ANCA (yes: no) | 26:8 (ratio 3,25:1) |
Type of ANCA (MPO: PR3) | 17:9 (ratio 1,9:1) |
Extrarenal manifestations | 23 (67.6%) |
Respiratory system | 19 (55.9%) |
Joints | 12 (35.3%) |
Gastrointestinal system | 7 (20.6%) |
Skin | 5 (14.7%) |
Muscles | 2 (5.9%) |
Genitourinary system | 1 (2.9%) |
Liver | 1 (2.9%) |
Plasma creatinine (mg/dl) | 6 ± 4.2 (range 0.8–19.4 mg/dl) |
Proteinuria (g/24 h) | 1.4 ± 0.96 (range 0.2–4.85 g/24 h) |
CRP (mg/l) | 72.8 ± 78 (range 3.4–272 mg/dl) |
Oligoanuria | 11 (32.3%) |
Dialysis | 14 (41.2%) |
Plasma exchange | 14 (41.2%) |
Follow-up (months) | 20 ± 22 (range 1–72 months) |